One Step Closer To Developing Non-Allergenic 'Super' Peanuts
News Jun 03, 2016
The world-first finding was carried out by scientists from UWA and several global research organisations including the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT).
The scientists identified the genes by decoding the DNA of peanuts. The discovery will also lead to increased crop productivity and nutritional value.
Peanuts are an important global food source and one the most economically important crops. They are grown in more than 100 countries, with approximately 42 million tonnes produced every year.
Peanut allergies have a high prevalence in Australia, affecting approximately 3 per cent of the population and can cause a severe allergic response if not treated quickly.
Professor Rajeev Varshney, Research Program Director- Genetic Gains from ICRISAT and also Winthrop Research Professor with UWA’s Institute of Agriculture and School of Plant Biology played a lead role in the study.
Professor Varshney said the findings were an important achievement for the agricultural industry and farming community.
“This discovery brings us that one step closer to creating peanuts that will have significant benefits globally,” Professor Varshney said.
“We will also be able to produce peanuts that have more health benefits with improved nutritional value.”
Professor Varshney said the next step would be to alter the genes the researchers had identified in the study and test the results in geocarpy (the productive process in the peanut), to develop new varieties of peanuts.
With approximately 80 percent of our nation's water supply going towards agriculture, it's fair to say it takes a lot of water to grow crops. In a climate with less predictable rainfall patterns and more intense droughts, scientists are working to reduce water consumption by developing more efficient crops.READ MORE
While the sight of black or white truffle being shaved over on pasta is generally considered a sign of dining extravagance, they play an important role in soil ecosystem services. Researchers have now conducted a comparative analysis of eight Pezizomycete fungi, including four species prized as delicacies.READ MORE
As genome editing technologies advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. However, challenges need to be addressed before potential treatments can be widely used in patients. To tackle these challenges, the National Institutes of Health has launched the Somatic Cell Genome Editing program, which has awarded multiple grants including more than $3.6 million to assess the safety of genome editing in human cells and tissues.